文献速递核素与放射性配体治疗

靶向α治疗:从「局部-区域-全身」三个维度对生物学效应的综合分析

Targeted alpha therapy: a comprehensive analysis of the biological effects from "local-regional-systemic" dimensions.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-06-11

本文综述靶向α治疗(TAT)的放射生物学机制,指出α发射体较β发射体具有传能线密度更高、穿透距离更短、抗乏氧能力更强及辐射防护更便利等特性,并可对部分β放疗耐药肿瘤显示疗效。文中系统分析TAT的靶向效应、旁效应与远隔效应三重抗肿瘤机制,构建「局部-区域-全身」多维抗肿瘤网络。

要点

  • α发射体较β发射体传能线密度更高、穿透距离更短、抗乏氧能力更强,辐射防护更便利。
  • TAT的抗肿瘤机制包括靶向效应、旁效应与远隔效应,构成「局部-区域-全身」多维网络。
  • 2013年首个α粒子治疗药物²²³RaCl₂(Xofigo®)获FDA批准用于晚期去势抵抗性前列腺癌骨转移。

核心结论

  • α粒子介导治疗效应的生物学机制尚未完全阐明,这阻碍了精准治疗策略的优化。
  • 本文构建的「局部-区域-全身」多维抗肿瘤网络既阐明α发射体的放射生物学原理,也为推进TAT在肿瘤精准治疗中的应用提供新视角。

研究设计与样本

  • 本文为综述,系统分析靶向α治疗的三重抗肿瘤机制:靶向效应、旁效应与远隔效应。

主要发现

  • 与β发射体相比,α发射体具有传能线密度更高、穿透距离更短、抗乏氧能力更强和辐射防护更便利等优势。
  • α发射体对一部分对β放疗耐药的肿瘤也显示出治疗疗效。
  • 2013年首个α粒子治疗药物²²³RaCl₂(Xofigo®)获FDA批准,用于治疗晚期去势抵抗性前列腺癌的骨转移,是α发射体临床转化的里程碑。

局限性

  • 原文指出α粒子介导治疗效应的生物学机制仍未完全阐明,原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Targeted alpha therapy (TAT) has emerged as a promising radiopharmaceutical modality in precision oncology. Compared to beta-emitters, alpha-emitters exhibit superior properties, including higher linear energy transfer, shorter penetration range, enhanced resistance to hypoxic conditions, and convenient radiation protection. Notably, alpha-emitters also demonstrate therapeutic efficacy against a subset of tumors exhibiting resistance to beta-radiotherapy. In 2013, the first α-particle therapeutic agent, ²²³RaCl₂ (Xofigo®), was approved by the FDA for treating bone metastases in advanced castration-resistant prostate cancer, marking a milestone in clinical translation of alpha-emitters. However, the biological mechanisms underlying alpha-particle-mediated therapeutic effects remain incompletely elucidated, which has hindered the optimization of precision treatment strategies. This review systematically analyzes TAT's tripartite antitumor mechanisms-targeted effects, bystander effects and abscopal effects-thereby constructing a "local-regional-systemic" multidimensional antitumor network. This framework not only clarifies the radiobiological principles of α-emitters but also provides innovative perspectives for advancing TAT applications in tumor precision therapy.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Song Z, Zhang J, Qin S, et al. Targeted alpha therapy: a comprehensive analysis of the biological effects from "local-regional-systemic" dimensions. Eur J Nucl Med Mol Imaging. 2025. PMID: 40498155. doi:10.1007/s00259-025-07390-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。